Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by lonc17on Feb 21, 2024 11:49am
142 Views
Post# 35891032

CEO comparison

CEO comparisonI was reading about Mike Rose, CEO of Tourmaline Oil. 

He was awarded Candian CEO of the year.

There's an article/interview with him posted to the Calgary Herald. 

Reading it, you can see how much he cares about his company, the buisiness, employees AND shareholders. He is honest and exceptionally talented. He started in the industry as a geologist and went on to found and grow three very succesful companies. He communicates the truth clearly and regularly to the owners of the company (shareholders).

The comparison between Mike Rose and Matt Coffey is night and day. 

MC is not honest, he has over-promised and underdelivered forever. MC is a scientiest and he has never shown the necessary skills or talent to lead a company. He should never have been selected as CEO of ONC. 

MC cares about the c-suite and ensuring the gravy train of high salaries and excessive stock options continues as long as possible. He does not give a damn about existing shareholders. 

MC somtimes issues statements congratuting himself on past successes (like 2023, which in fact was a disastorous year for ONC) and assuring the market that P3's are coming soon!

MIke Rose is Canadian CEO of the year. Matt Coffee has to be one of the worst. 


<< Previous
Bullboard Posts
Next >>